Serena Williams sparked a heated debate after revealing she lost 31 pounds using a GLP-1 drug. While the tennis legend ...

The American Heart Association and the American College of Cardiology's new guidelines for 2025 emphasize early intervention.

Serena Williams has admitted to using weight-loss medication for over a year – and she’s making no excuses for her decision.

Eli Lilly and Novo Nordisk already produce popular GLP-1s in the Triangle. A Swiss drugmaker says its future Wake County site ...

FAT jabs have turned the tide on the obesity epidemic, but there’s a new challenge on the horizon – an obesity bounceback.

What do Oprah, Meghan Trainor, Kathy Bates, Fat Joe, Lizzo and Serena Williams all have in common? Their outspoken use of a glp-1 agonist to aid in weight loss and the improvement of other health ...

Williams is not the first sportsperson to promote GLP-1 weight loss medication but she is the most high profile and easily ...

Serena Williams has spent her life proving that hard work, persistence, and discipline can take you anywhere. But in a candid ...

GreensKeeper Asset Management, an investment management company, released its second-quarter 2025 investor letter. A copy of ...

Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” second-quarter 2025 ...

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...